Overview
Hamza Gorsi is a Pediatric Hematologist Oncology provider in Providence, Rhode Island. Dr. Gorsi is rated as an Experienced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Sickle Cell Disease, Glioma, Hemoglobinopathy, and Hemoglobin E Disease.
His clinical research consists of co-authoring 18 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- OTHER MEDICAID
- STATE MEDICAID
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER COMMERCIAL
- OTHER MEDICARE
- OTHER MEDICARE PART D
- HMO
- POS
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- EPO
- HMO
- POS
- PPO
Locations
Additional Areas of Focus
Dr. Gorsi has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Mark Kieran is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Kieran is rated as a Distinguished provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Glioma, Brain Stem Cancer, Diffuse Midline Glioma H3 K27M-Mutant, and Medulloblastoma.
Peter Manley is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Manley is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). His top areas of expertise are Ataxia-Telangiectasia, Glioma, Medulloblastoma, and Optic Glioma.
Natalie Collins is a Pediatric Hematologist Oncology provider in Boston, Massachusetts. Dr. Collins is rated as an Advanced provider by MediFind in the treatment of Neurofibromatosis Type 1 (NF1). Her top areas of expertise are Rhabdomyosarcoma, Neuroblastoma, Hereditary Neuroblastoma, and Ewing Sarcoma.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Gorsi isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Adult Soft Tissue SarcomaDr. Gorsi isExperienced. Learn about Adult Soft Tissue Sarcoma.
- Brain Stem CancerDr. Gorsi isExperienced. Learn about Brain Stem Cancer.
- Cerebral Ventricle CancerDr. Gorsi isExperienced. Learn about Cerebral Ventricle Cancer.
- Diffuse Midline Glioma H3 K27M-MutantDr. Gorsi isExperienced. Learn about Diffuse Midline Glioma H3 K27M-Mutant.
- Embryonal Tumor with Multilayered Rosettes